Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment. - Wikidata - wikimedia - TriplyDB

Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.

Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.

http://www.wikidata.org/entity/Q37182802

about

The retinoid X receptors and their ligands Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition Puerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition.Peroxisome proliferator-activated receptors and cancer: challenges and opportunities The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination.PPARgamma and Proline Oxidase in Cancer.Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.Peroxisome proliferator-activated receptor γ and colorectal cancer.PPAR gamma, bioactive lipids, and cancer progression.Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis.Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials.Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor γ Agonist In Vivo.PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.Peroxisome proliferator-activated receptor gamma ligands enhance human B cell antibody production and differentiation.

P2860

Q24562747-CEDBB8B3-E049-4C84-B879-79E3AA5D500F Q30498249-F1723D4C-E5A8-4487-A86D-E93A2A054722 Q33790719-4242F50A-E826-41A3-B584-40BE69896761 Q35210023-B526A254-634B-4B3D-8734-2F198500CEDA Q36090448-1F1E31F5-BE37-4E1F-B30E-3EAEEEA8E650 Q36798663-FE1C8BFB-F4C3-4478-A99A-3AD33E42B01F Q37345052-CD31C5F8-D296-4658-8326-CB56166C57D0 Q37821269-9837C020-C507-47DA-97FD-89273489DE83 Q37971590-741CB54C-83D3-4809-BBA0-EEFD524F29ED Q38066478-CCADE845-85C4-4E23-BF9A-6DF91E4C5BA3 Q39162746-528131AD-AF3F-4E56-8AE6-2F88C5E52EB7 Q39609137-7B81689D-8CFD-4E9D-B641-1A1950A03BF5 Q39750509-9DB21DAF-D36F-42D9-A6BC-1CFE9932F463 Q39849095-B4C250B6-AF8B-4678-B3B9-62CDCED011E3 Q42210954-9C748FF1-EE3F-4A51-9E8F-B1236E946213

P2860

Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.

http://www.wikidata.org/entity/Q37182802

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.

@en

Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.

@nl

type

label

Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.

@en

Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.

@nl

prefLabel

Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.

@en

Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.

@nl

P1433

Q37182802-6300A303-0A4A-4BEA-BA8C-910F1A9326E0

P1476

Q37182802-6463B3A8-F6A3-4B68-B69C-A9141C631546

P2093

Q37182802-02EF6691-4D98-4F9D-9147-419DD3C2CDAB

Q37182802-BD95DF18-547C-4FE9-A848-8C97F3F691E3

P2860

Q37182802-00379794-75DD-4B1F-9D92-63A074C64611

Q37182802-05345835-50CB-47ED-9E30-93166725C3BB

Q37182802-05792346-6CFB-4B68-BB32-784FF46B5CE5

Q37182802-059D0B08-368B-419E-B35A-D91B8E93377D

Q37182802-0AD812D2-893F-4B80-9F04-75D01A778369

Q37182802-0EA44DB4-35FC-4260-82F5-0D02F0D32532

Q37182802-0FC71607-7615-4370-A281-FB350498D8D8

Q37182802-17703422-A5B6-4A45-8515-A6627C4D305C

Q37182802-19958B10-1D70-4F2D-AD40-B626002AB77E

Q37182802-1FC61E14-1ABA-4384-BF98-41E9E7F59AF6

P304

Q37182802-6F042947-C98C-4576-B145-6EDDF7F51450

P31

Q37182802-340EE193-E913-40A2-97FA-F36BFCB34A4B

P356

Q37182802-8ED44901-891D-4789-BA99-48EEB616214C

P478

Q37182802-6BD1167C-E469-4721-B852-B645D0B67157

P577

Q37182802-5D49677B-4139-4AC7-9EEF-41DEAD44F70D

P5875

Q37182802-FB4AF59D-2812-4207-9130-384C4336C88E

P698

Q37182802-F0C6876B-9015-4580-9977-B7DDB1030B26

P932

Q37182802-4DBCCD0D-EA01-4F29-8200-06FFCBAADEFF

P356

P1433

P1476

Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.

@en

P2093

Hisataka Moriwaki

http://www.w3.org/2001/XMLSchema#string

Masahito Shimizu

http://www.w3.org/2001/XMLSchema#string

P2860

Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis

Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid

A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor li

The nuclear receptor superfamily: the second decade

The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation

Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists

Retinoid X receptors: X-ploring their (patho)physiological functions

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

A decade of molecular biology of retinoic acid receptors

P304

181047

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2008/181047

http://www.w3.org/2001/XMLSchema#string

P478

2008

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5328345

http://www.w3.org/2001/XMLSchema#string

P698

18528526

http://www.w3.org/2001/XMLSchema#string

P932

2408709

http://www.w3.org/2001/XMLSchema#string